Arcus Biosciences Inc (RCUS)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 485,000 | 565,000 | 635,000 | 707,000 | 462,000 | 520,000 | 566,000 | 600,000 | 657,000 | 699,000 | 747,000 | 797,000 | 842,000 | 542,607 | 604,555 | 664,790 | 502,000 | 544,417 | 428,710 | 140,638 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $485,000K
= 0.00
The debt-to-equity ratio of Arcus Biosciences Inc has consistently been 0.00 for the periods from March 31, 2020, to December 31, 2024. This indicates that the company has been financing its operations primarily through equity rather than debt during this period. A debt-to-equity ratio of 0.00 implies that the company has no debt in its capital structure relative to its equity. It suggests that Arcus Biosciences Inc may have a conservative approach to capital structure, maintaining a low level of debt compared to its equity. This could indicate a lower financial risk for the company, as it relies less on borrowed funds to finance its operations and growth.
Peer comparison
Dec 31, 2024